forum

NECLIFE Share Price Discussion

Nectar Lifesciences Ltd.
Sector: Pharmaceuticals and health care
... Read more
NECLIFE Share Price *
14.7 +0.3 (2.08%)
* (quote may be delayed)

NECLIFE Discussion Forum


NECLIFE - 326711
Fire/ explosion in Unit II of the company at Village Saidpura, Tehsil Derabassi, Distt. S.A.S. Nagar (Mohali) Punjab'.
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
  • NECLIFE - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization383.55
    Enterprise Value1,164.97
    Price to Earnings11.41
    Price to Book Value0.35
    Return on Capital Employed0.09
    Return on Equity0.05
    Face Value1
    Dividend YieldNA
  • NECLIFE Share Price - Technicals

    keyboard_arrow_down
    NECLIFE - 52 Week High₹28.3
    NECLIFE - 52 Week Low₹12.55
  • NECLIFE Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 1614.415.3514.3514.7
    Sep 1314.314.714.314.4
    Sep 1214.9515.314.514.65
    Sep 1114.815.3514.614.9
    Sep 913.1515.412.9514.5
  • NECLIFE Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹13.6
    30 Day Moving Average₹13.79
    50 Day Moving Average₹13.93
    100 Day Moving Average₹15.26
    200 Day Moving Average₹16.97
  • NECLIFE - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue1,8731,643.340.14
    Operating Profit236224.220.05
    Profit Before Tax6367.21-0.06
    Net Income5255.13-0.06
  • NECLIFE - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds1,1041,0580.04
    Total Liabilities1,6001,665-0.04
    Total Assets2,7042,724-0.01
  • NECLIFE - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity65198.62-0.67
    Cash from Investing Activity-29-18.110.6
    Cash from Financing Activity-40-204.12-0.8
    Net Cash Flow-4-23.6-0.83
  • NECLIFE - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.020.02
    Return on Equity0.050.05
    Return on Capital Employed0.090.1
  • NECLIFE - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.14
    3 Year CAGR Growth in Operating Profit-0.12
    3 Year CAGR Growth in EBIDTA-0.16
    3 Year CAGR Growth in Net Income-0.22
    3 Yr CAGR Growth - Diluted EPS-0.21
  • NECLIFE - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.15
    5 Year CAGR Growth in Operating Profit-0.19
    5 Year CAGR Growth in EBIDTA-0.21
    5 Year CAGR Growth in Net Income-0.39
    3 Yr CAGR Growth - Diluted EPS-0.39
  • NECLIFE Share Price - Recent News

    keyboard_arrow_down
    NewsBot
    May 27 5:48 PM
    NewsBot
    Feb 11 11:22 PM
    NewsBot
    Nov 15 6:57 PM
  • NECLIFE - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.